Frailty Subgroups Determine Heterogeneous Outcomes in Elderly Patients with Newly-Diagnosed Multiple Myeloma- Long-Term Follow-up of the HOVON 143 Trial

Smits, F., Groen, K., Levin, M.-D., Stege, C. A. M., Kampen, R. J. W. V., van der Spek, E., Bilgin, Y. M., Thielen, N., Nijhof, I. S., Ludwig, I., Waal, E. G. M. D., Sandberg, Y., Kentos, A., Timmers, G. J., Regelink, J. C., Westerman, M., de Heer, K., Vekemans, M. C., Durdu-Rayman, N. & de Graauw, N. & 5 others, Seefat, M. R., Donk, N. W. C. J. V. D., Ypma, P. F., Nasserinejad, K. & Zweegman, S., 5 Nov 2024, In: Blood. 144, p. 4739-4740 2 p.

Research output: Contribution to journal › Meeting Abstract › Academic › peer-review